"I got it in my head that I just want to cure one person -- and the only way you can do that is to commercialize." Health Sciences researchers share their experiences with trying to move their findings from the bench to the clinic.
A Hamilton patient is the first trial participant to receive a novel experimental immunotherapy treatment for lung cancer.
McMaster, along with The Ottawa Hospital, the Children’s Hospital of Eastern Ontario and the University of Ottawa have congratulated Turnstone Biologics Inc.3 on securing $41.4 million U.S. in new private investments.
McMaster logo
McMaster logo
